Macrogenics (MGNX) Tops Q3 EPS by 38c

Macrogenics (NASDAQ: MGNX) reported Q3 EPS of $0.28, $0.38 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $10.39 million versus the consensus estimate of $49.24 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• Investing.com’s stocks of the week
• ExxonMobil Q2 profit falls short of forecasts, shares slide
• Regal-Beloit (RBC) Tops Q1 EPS by 47c; offers guidance